Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    14767435 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug
Conditions: Asthma;   Allergy;   Allergic Rhinitis;   Rhinitis, Allergic, Seasonal
Intervention: Drug: Amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate (AIC)

Study has passed its completion date and status has not been verified in more than two years.